Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v2.4.1.9
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Operating Activities:    
Net loss $ (4,517)us-gaap_NetIncomeLoss $ (8,636)us-gaap_NetIncomeLoss
Adjustments to reconcile net loss to net cash used in operating activities:    
(Gain) loss on warrants (465)us-gaap_FairValueAdjustmentOfWarrants 721us-gaap_FairValueAdjustmentOfWarrants
Depreciation 46us-gaap_Depreciation 55us-gaap_Depreciation
Stock-based compensation [note 5 [c] and note 5 [d]] 516us-gaap_ShareBasedCompensation 1,000us-gaap_ShareBasedCompensation
Changes in operating assets and liabilities:    
Interest receivable 42us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet 52us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet
Amounts receivable 4,117us-gaap_IncreaseDecreaseInAccountsReceivable 47us-gaap_IncreaseDecreaseInAccountsReceivable
Prepaid expenses and other assets (842)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets 3,985us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
Accounts payable 916us-gaap_IncreaseDecreaseInAccountsPayableTrade 784us-gaap_IncreaseDecreaseInAccountsPayableTrade
Accrued liabilities other (1,849)us-gaap_IncreaseDecreaseInOtherAccruedLiabilities 1,257us-gaap_IncreaseDecreaseInOtherAccruedLiabilities
Accrued clinical liabilities (3,797)us-gaap_IncreaseDecreaseInAccruedLiabilities  
Accrued compensation (602)us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities (801)us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities
Restricted cash 61us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities 63us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities
Excess lease liability [note 6] (194)us-gaap_IncreaseDecreaseInRestructuringReserve (189)us-gaap_IncreaseDecreaseInRestructuringReserve
Lease obligation 124ogxi_IncreaseDecreaseInLeaseObligations (30)ogxi_IncreaseDecreaseInLeaseObligations
Net cash used in operating activities (6,444)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (1,692)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Financing Activities:    
Proceeds from the exercise of stock options   30us-gaap_ProceedsFromStockOptionsExercised
Taxes paid related to net share settlement of equity awards (52)us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation  
Net cash (used) provided by financing activities (52)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations 30us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Investing Activities:    
Purchase of investments   (51)us-gaap_PaymentsForProceedsFromShortTermInvestments
Proceeds from sale of investments 1,071us-gaap_ProceedsFromSaleOfShortTermInvestments  
Proceeds from maturities of investments 3,011us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments 15,758us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
Purchase of property and equipment (205)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (7)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Net cash provided by (used in) investing activities 3,877us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations 15,700us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
Effect of exchange rate changes on cash   (1)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents
Net increase (decrease) in cash and cash equivalents (2,619)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease 14,037us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents at beginning of year 27,897us-gaap_CashAndCashEquivalentsAtCarryingValue 14,593us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents at end of year $ 25,278us-gaap_CashAndCashEquivalentsAtCarryingValue $ 28,630us-gaap_CashAndCashEquivalentsAtCarryingValue